Φορτώνει......
Intravenous Iron Replacement Therapy Improves Cardiovascular Outcomes in Hemodialysis Patients
Background/Aim: More than half of deaths among hemodialysis patients are due to cardiovascular disease. This study examined whether intravenous administration of ferric carboxymaltose (FCM) has an impact on cardiovascular events in iron-deficient hemodialysis patients. Patients and Methods: We perfo...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | In Vivo |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
International Institute of Anticancer Research
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8193293/ https://ncbi.nlm.nih.gov/pubmed/33910844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12419 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|